Related Experiment Video
Updated: Mar 23, 2026
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Gene mutations in chronic lymphocytic leukemia
1Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
Abstract:
The recent discovery of genes mutated in chronic lymphocytic leukemia (CLL) has stimulated new research into the role of these genes in CLL pathogenesis. CLL cases carry approximately 5-20 mutated genes per exome, a lower number than detected in many human tumors. Of the recurrently mutated genes in CLL, all are mutated in 10% or less of patients when assayed in unselected CLL cohorts at diagnosis. Mutations in TP53 are of major clinical relevance, are often associated with del17p and gain in frequency over time. TP53 mutated and associated del17p states substantially lower response rates, remission duration, and survival in CLL. Mutations in NOTCH1 and SF3B1 are recurrent, often associated with progressive CLL that is also IgVH unmutated and ZAP70-positive and are under investigation as targets for novel therapies and as factors influencing CLL outcome. There are an estimated 20-50 additional mutated genes with frequencies of 1%-5% in CLL; more work is needed to identify these and to study their significance. Finally, of the major biological aberration categories influencing CLL as a disease, gene mutations will need to be placed into context with regard to their ultimate role and importance. Such calibrated appreciation necessitates studies incorporating multiple CLL driver aberrations into biological and clinical analyses.
Insights
Genetic mutations in chronic lymphocytic leukemia (CLL) are key to understanding disease development. Identifying these mutations, like TP53, is crucial for predicting patient outcomes and developing targeted therapies.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Chronic lymphocytic leukemia (CLL) pathogenesis is increasingly understood through genetic mutations.
- CLL cases exhibit a relatively low number of mutated genes per exome compared to other cancers.
- Recurrently mutated genes in CLL are found in 10% or fewer patients at diagnosis.
Purpose of the Study:
- To review the role of gene mutations in CLL pathogenesis.
- To highlight the clinical significance of specific mutations like TP53, NOTCH1, and SF3B1.
- To emphasize the need for further research into less frequent mutations and their combined impact.
Main Methods:
- Review of recent discoveries in CLL genetics.
- Analysis of mutation frequencies in CLL cohorts.
- Correlation of genetic mutations with clinical outcomes and disease progression.
Main Results:
- TP53 mutations, often with del17p, significantly reduce treatment response, remission duration, and survival in CLL.
- NOTCH1 and SF3B1 mutations are associated with progressive CLL, IgVH unmutated status, and ZAP70 positivity.
- Numerous additional low-frequency mutated genes (1-5%) in CLL require further identification and study.
Conclusions:
- Gene mutations are critical drivers of CLL pathogenesis and clinical outcome.
- Understanding specific mutations like TP53, NOTCH1, and SF3B1 is vital for prognostication and therapeutic targeting.
- Future research must integrate multiple genetic aberrations to fully appreciate their role in CLL biology and clinical management.
More Related Videos
Related Concept Videos
01:39Mutations
01:35Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
01:18Mutations in Microorganisms
03:18Non-LTR Retrotransposons